| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 07/05/2000 | EP0697021B1 Photo-activatable biotin derivatives and their use in suppressing interference in immuno assaying |
| 07/05/2000 | EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 07/04/2000 | US6084062 Polypeptides that bind to tissue plasminogen activator (tPA) |
| 07/04/2000 | US6083708 Polypeptide: dendrimer complexes |
| 07/04/2000 | US6083478 Consists of a cytotoxic radionuclide and a homodimer comprising two heavy chains encoded by the expression vector designated cd4-igg2-pcdna1 (atcc no. 40952) |
| 06/29/2000 | WO2000009073A3 Blood-brain barrier therapeutics |
| 06/28/2000 | EP1013669A2 Method for immobilization of compounds |
| 06/28/2000 | EP1012289A1 A recombinant expression vector of human parathyroid hormone using phosphoribulokinase as a fusion partner |
| 06/22/2000 | WO2000036145A1 Method for making a biochip and biochip |
| 06/22/2000 | WO2000036136A1 Metallopeptide combinatorial libraries and applications |
| 06/22/2000 | WO2000023955A8 Virus-like particles for the induction of autoantibodies |
| 06/22/2000 | WO2000010599A3 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE |
| 06/22/2000 | CA2353072A1 Metallopeptide combinatorial libraries and applications |
| 06/21/2000 | EP1009831A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 06/21/2000 | EP1009759A1 Carbohydrate crosslinked glycoprotein crystals |
| 06/20/2000 | US6077939 Methods and kits for making polypeptides having a single covalently bound N-terminal water-soluble polymer |
| 06/20/2000 | US6077707 Long wavelength engineered fluorescent proteins |
| 06/20/2000 | US6077698 Nonpolymeric compound including at least two aryl ketones and one or more sulfonate, phosphonate, and carboxylate groups; for surface treatments and immobilization in aqueous systems |
| 06/15/2000 | WO2000034784A1 Protein scaffolds for antibody mimics and other binding proteins |
| 06/15/2000 | WO2000033881A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 06/15/2000 | WO2000033865A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | WO2000006726A3 Delta-related polypeptides |
| 06/15/2000 | CA2354868A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 06/15/2000 | CA2354189A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | CA2351346A1 Protein scaffolds for antibody mimics and other binding proteins |
| 06/14/2000 | EP1008355A1 Method for identifying or analyzing polymer linkage sites on macromolecules using amino acid report binding |
| 06/14/2000 | EP1007554A1 Oil bodies and associated proteins as affinity matrices |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents |
| 06/13/2000 | US6074650 Membrane anchor/active compound conjugate, its preparation and its uses |
| 06/08/2000 | WO2000032823A1 Dna-protein fusions and uses thereof |
| 06/08/2000 | WO2000032767A1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 06/08/2000 | WO2000012536A3 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 06/08/2000 | CA2352539A1 Recombinant soluble fc receptors |
| 06/07/2000 | EP1006183A1 Recombinant soluble Fc receptors |
| 06/07/2000 | EP1005495A1 Aminoalkyl trialkyl silyl cellulose and a method for coating surfaces |
| 06/07/2000 | EP1005373A1 Modified polypeptides with high activity and reduced allergenicity |
| 06/06/2000 | US6072045 Chimeric isoprenoid synthases and uses thereof |
| 06/06/2000 | CA1341014C Hcg peptides for use in antibody purification procedures |
| 06/02/2000 | WO2000031114A1 DNA ENCODING PROTEINS THAT INHIBIT Hsp70 FUNCTION |
| 06/02/2000 | WO2000012587A3 Polyamide chains of precise length, methods to manufacture them and their conjugates |
| 05/31/2000 | EP1003853A1 Methods for protein screening |
| 05/30/2000 | CA2045200C Immobilization of biomolecules by enhanced electophoretic precipitation |
| 05/25/2000 | WO2000029548A2 Coupled peptides |
| 05/25/2000 | CA2345934A1 Coupled peptides |
| 05/24/2000 | EP1002064A1 A modified polypeptide |
| 05/24/2000 | EP1001992A2 Method for transglutaminase-catalyzed coupling of protein or peptide to a support |
| 05/23/2000 | US6066320 Isolating antiserum with nerve cells presenting anti-prion protein |
| 05/17/2000 | EP1000081A2 A reversible stoichiometric process for conjugating biomolecules |
| 05/17/2000 | EP0620825B1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 05/11/2000 | WO2000025725A2 Functional antagonists of hedgehog activity |
| 05/09/2000 | US6060588 Bap-1 proteins |
| 05/09/2000 | US6060056 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 05/09/2000 | CA1340985C Peptide derivatives |
| 05/03/2000 | EP0585436B1 Immobilization of chemical species in crosslinked matrices |
| 05/03/2000 | EP0383803B1 Oligonucleotide-polyamide conjugates |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023478A1 Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | CA2346871A1 Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
| 04/27/2000 | CA2343094A1 Interferon-beta fusion proteins and uses |
| 04/26/2000 | EP0995761A2 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0771209A4 Novel peptides |
| 04/25/2000 | US6054321 Forming three-dimensional structure of a fluorescent protein, constructing model of other fluorescent protein using first as template, making mutants by replacing amino acid(s) within 5 angstroms of any atom of chromophore |
| 04/25/2000 | CA2106079C Pegylation of polypeptides |
| 04/20/2000 | WO2000021567A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 04/20/2000 | CA2346066A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 04/18/2000 | US6051549 Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof |
| 04/18/2000 | US6051384 Method of detecting p53-specific antibodies |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/12/2000 | EP0991944A1 Methods for covalent immobilisation of biomolecules to a carrier by means of a his-tag |
| 04/11/2000 | US6048720 Conjugates of a polypeptide and a biocompatible polymer |
| 04/11/2000 | US6048530 Inducing cytotoxic t-cell response against viruses, bacteria, fungi, and parasites; immunology |
| 04/06/2000 | WO2000018823A2 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 04/06/2000 | CA2345332A1 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 04/04/2000 | US6046024 Method of producing a fibrin monomer using a biotinylated enzyme and immobilized avidin |
| 04/04/2000 | US6045818 Cell growth substrates with tethered cell growth effector molecules |
| 03/29/2000 | EP0988314A1 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/29/2000 | EP0777689B1 Use of cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 03/28/2000 | US6043347 Compositions and methods for treating viral infections |
| 03/22/2000 | EP0986533A1 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis |
| 03/15/2000 | EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS |
| 03/14/2000 | CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/09/2000 | WO2000012587A2 Polyamide chains of precise length, methods to manufacture them and their conjugates |
| 03/09/2000 | WO2000012536A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/09/2000 | CA2351739A1 Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins |
| 03/09/2000 | CA2351547A1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/08/2000 | EP0983354A2 Neurotrophic factor receptors |
| 03/08/2000 | EP0910601B1 Azlactone-derivatized polyamides |
| 03/07/2000 | US6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 03/02/2000 | WO2000010599A2 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE |
| 03/02/2000 | WO1999000670A8 Methods for covalent immobilisation of biomolecules to a carrier by means of a his-tag |
| 03/02/2000 | CA2340692A1 Immunogenic .beta.-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
| 03/01/2000 | EP0981364A1 Method and compositions for treating hyperlipidemia and other conditions |
| 03/01/2000 | EP0666760B1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
| 02/29/2000 | CA2003662C Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
| 02/24/2000 | WO2000009165A1 Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 02/24/2000 | WO2000009073A2 Blood-brain barrier therapeutics |
| 02/24/2000 | CA2340418A1 Blood-brain barrier therapeutics |